Home » Stocks » Amedisys

Amedisys Inc. (AMED)

Stock Price: $235.39 USD 2.18 (0.93%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 7.64B
Revenue (ttm) 1.97B
Net Income (ttm) 128.26M
Shares Out 32.47M
EPS (ttm) 3.86
PE Ratio 60.98
Forward PE 54.64
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $235.39
Previous Close $233.21
Change ($) 2.18
Change (%) 0.93%
Day's Open 232.80
Day's Range 229.85 - 236.85
Day's Volume 173,962
52-Week Range 121.00 - 237.28

More Stats

Market Cap 7.64B
Enterprise Value 7.96B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 32.47M
Float 32.09M
EPS (basic) 3.97
EPS (diluted) 3.86
FCF / Share 7.89
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.64%
FCF Yield 3.35%
Payout Ratio n/a
Shares Short 1.22M
Short Ratio 1.59
Short % of Float 3.34%
Beta 0.94
PE Ratio 60.98
Forward PE 54.64
P/FCF Ratio 29.87
PS Ratio 3.88
PB Ratio 10.55
Revenue 1.97B
Operating Income 182.20M
Net Income 128.26M
Free Cash Flow 255.83M
Net Cash -314.67M
Net Cash / Share -9.69
Gross Margin 40.84%
Operating Margin 9.24%
Profit Margin 6.50%
FCF Margin 12.97%
ROA 7.89%
ROE 20.15%
ROIC 35.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (14)

Buy 9
Overweight 2
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$252.23*
(7.15% upside)
Low
235
Current: $235.39
High
270
Target: 252.23
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,9561,6631,5111,4191,2811,2051,2491,4411,4181,601
Revenue Growth17.63%10.01%6.48%10.83%6.31%-3.59%-13.29%1.58%-11.41%-
Gross Profit805670608585555513531630668807
Operating Income17715578.5257.34-9.1724.05-155-109-469211
Net Income12711930.3037.26-3.0212.78-96.18-83.59-382113
Shares Outstanding32.1432.7933.7033.2033.0232.3031.2529.9028.6928.03
Earnings Per Share3.843.550.881.10-0.090.39-3.08-2.79-13.333.95
EPS Growth8.17%303.41%-20%-------
Operating Cash Flow20222310662.26108-65.5310269.49141206
Capital Expenditures-7.73-6.50-10.46-15.72-1.43-12.01-39.93-47.63-44.42-63.92
Free Cash Flow19421795.2746.54106-77.5462.3421.8696.80142
Cash & Equivalents96.4920.2386.3630.2027.508.0317.3014.5548.00120
Total Debt3267.3988.8493.0396.6311646.90103145182
Net Cash / Debt-23012.84-2.48-62.83-69.13-108-29.60-88.17-97.44-61.57
Assets1,2637178137346826707267318581,300
Liabilities621234297273271272354276338420
Book Value640482515460410397372452519878
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Amedisys Inc.
Country United States
Employees 21,000
CEO Paul B. K. Kusserow

Stock Information

Ticker Symbol AMED
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NASDAQ: AMED

Description

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.